Comparisons

Ozempic vs Trulicity: Which GLP-1 Medication Is Right for You?

If you're considering a GLP-1 medication for weight loss or diabetes management, you've likely come across both Ozempic and Trulicity. Both are once-weekly injections that have transformed how we approach metabolic health, but they're not identical twins. Understanding the differences between these two medications can help you have a more informed conversation with your doctor about which might work best for your body and your goals.

Let's break down what makes each medication unique, how they compare in real-world use, and what you should consider when choosing between them.

What Are Ozempic and Trulicity?

Both Ozempic and Trulicity belong to a class of medications called GLP-1 receptor agonists. They work by mimicking a natural hormone in your body that regulates blood sugar, slows digestion, and signals feelings of fullness to your brain.

Ozempic contains the active ingredient semaglutide and was FDA-approved in 2017 primarily for type 2 diabetes. Trulicity contains dulaglutide and received FDA approval in 2014, also for type 2 diabetes management.

While both medications were initially developed for blood sugar control, they've gained significant attention for their weight loss effects. Many patients experience meaningful weight reduction as a welcome benefit of treatment.

How They Compare in Effectiveness

Blood Sugar Control

Both medications effectively lower A1C levels, which measure average blood sugar over three months. Clinical studies show that Ozempic tends to produce slightly greater A1C reductions compared to Trulicity, with patients on Ozempic seeing average drops of 1.5-1.8% versus 1.1-1.5% with Trulicity.

That said, both medications significantly outperform older diabetes drugs and help many people reach their blood sugar targets.

Weight Loss Results

This is where the two medications show more noticeable differences. Ozempic generally leads to greater weight loss than Trulicity in head-to-head comparisons.

In clinical trials, patients taking Ozempic at the highest dose lost an average of 12-14 pounds over 40 weeks, while those on Trulicity lost approximately 6-10 pounds. Individual results vary widely, but the overall trend shows semaglutide producing more significant weight reduction.

Women often ask whether these medications work differently based on gender. While both men and women see results, some research suggests women may experience slightly more gastrointestinal side effects initially, though weight loss outcomes are generally comparable between genders when adjusted for starting weight.

Dosing and Administration

Both medications come as pre-filled pens that you inject once weekly under your skin, typically in your abdomen, thigh, or upper arm. You don't need to take them with food, and you can adjust your injection day if needed.

Ozempic Dosing

Ozempic starts at 0.25 mg weekly for the first month, then increases to 0.5 mg. Your doctor may increase it further to 1 mg or 2 mg depending on your response and tolerance. The gradual increase helps your body adjust and minimizes side effects.

Trulicity Dosing

Trulicity begins at 0.75 mg weekly and can be increased to 1.5 mg, 3 mg, or 4.5 mg. The pen design is slightly different, with a hidden needle that some patients find less intimidating if you're nervous about injections.

Side Effects: What to Expect

Because both medications work similarly, they share common side effects. The most frequent complaints include nausea, diarrhea, constipation, stomach pain, and reduced appetite.

Most side effects are mild to moderate and improve after the first few weeks as your body adjusts. Starting at a low dose and increasing gradually helps minimize discomfort.

Ozempic may cause slightly more nausea in some patients, particularly at higher doses. However, this varies considerably from person to person—some people sail through treatment with minimal issues on either medication.

Serious side effects are rare but can include pancreatitis, gallbladder problems, and kidney issues. Both medications carry a warning about thyroid tumors based on animal studies, though this hasn't been confirmed in humans. Neither should be used if you have a personal or family history of medullary thyroid cancer.

Cost Considerations

Without insurance, both Ozempic and Trulicity are expensive—often $900-1,000+ per month at retail prices. Insurance coverage varies widely depending on your plan and whether you're using the medication for diabetes or weight loss.

For diabetes management, most insurance plans cover one or both medications, though you may need prior authorization. For weight loss alone, coverage is less common, leaving many patients paying out of pocket or seeking more affordable alternatives.

Compounded semaglutide (the same active ingredient as Ozempic) has become a cost-effective option for many people, offering the benefits of GLP-1 therapy at a fraction of the brand-name price.

Which One Is Right for You?

The best medication depends on your individual health profile, goals, and how your body responds to treatment.

Ozempic might be the better choice if:

Trulicity might work better if:

Remember, medication choice isn't one-size-fits-all. What works beautifully for your friend or family member might not be the ideal fit for you. Your response to treatment, existing health conditions, other medications you take, and personal preferences all factor into the decision.

From the Ozari Care Team

When starting any GLP-1 medication, we recommend eating smaller, more frequent meals during the first few weeks to minimize nausea. Stay well-hydrated and avoid high-fat foods initially, as they can worsen stomach discomfort. Most patients find side effects peak around day 2-3 after injection and improve significantly by week 4-6 of treatment.

Affordable GLP-1 Therapy at Ozari Health

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Our care team provides ongoing support to help you achieve your metabolic health goals. Learn more at ozarihealth.com.

Medically Reviewed — Ozari Clinical Content Team (OCCT). Health writers and wellness professionals specializing in GLP-1 therapy, metabolic health, and weight loss medicine. Content reviewed in accordance with Ozari's Editorial Standards. Last reviewed: April 25, 2026.

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

Last reviewed: April 25, 2026